Tiny retinal chip offers hope for age-related macular degeneration patients

Age-related macular degeneration causes severe vision impairment and blindness in millions of people worldwide. A novel medical advancement involving a microscopic chip implanted beneath the retina is offering new possibilities to restore sight for affected individuals. The technology operates by bypassing damaged photoreceptor cells in the eye, potentially enabling patients suffering from progressive vision loss to regain functional sight capabilities.

In addition to retinal microchip implants, medical researchers are advancing innovative cellular therapies, such as CAR-T cell treatments, to target complex degenerative and autoimmune conditions. These clinical developments represent notable progress in experimental ophthalmology and regenerative medicine, aiming to significantly enhance the independence and quality of life for individuals facing vision loss.

Sources: FAZ